Short interest in Day One Biopharmaceuticals Inc (NASDAQ:DAWN) increased during the last reporting period, rising from 15.98M to 18.02M. This put 21.58% of the company's publicly available shares short.

Short interest for Day One Biopharmaceutical gives investors a sense of the degree to which investors are betting on the decline of Day One Biopharmaceutical's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.13M shares traded per day, it would take 15.92 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.